Overview

N-acetylcysteine in the Treatment of Depressive Symptoms in Bipolar Offspring

Status:
Unknown status
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
N-acetylcysteine in the treatment of depressive symptoms in youth at high-risk for bipolar disorder: a functional connectivity study
Phase:
N/A
Details
Lead Sponsor:
University of Cincinnati
Treatments:
Acetylcysteine
N-monoacetylcystine